James D McFadyen Selected Research

James D McFadyen Research Topics

Disease

7	Hemorrhage 01/2022 - 01/2017
6	Thrombosis (Thrombus) 01/2022 - 01/2018
4	Inflammation (Inflammations) 01/2020 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
3	Neoplasms (Cancer) 01/2019 - 02/2014
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2020
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 08/2019
2	Acute Coronary Syndrome 01/2022 - 01/2018
2	Atrial Fibrillation 11/2020 - 10/2020
2	Reperfusion Injury 10/2020 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2018
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 11/2019
2	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 01/2018
2	Hemophilia A (Haemophilia) 01/2017 - 11/2016
1	Atherosclerosis 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Abdominal Aortic Aneurysm 01/2022
1	Myocardial Infarction 10/2020
1	Thromboinflammation 01/2020
1	Pulmonary Embolism 01/2020
1	COVID-19 01/2020
1	Stroke (Strokes) 01/2020
1	Rupture 08/2019
1	Aortic Valve Stenosis (Aortic Stenosis) 02/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Ischemia 01/2018
1	von Willebrand Diseases (von Willebrand's Disease) 01/2017
1	Thrombotic Thrombocytopenic Purpura 11/2016
1	Hematologic Diseases (Blood Diseases) 11/2016
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2016
1	Autoimmune Diseases (Autoimmune Disease) 11/2016
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 11/2016

Drug/Important Bio-Agent (IBA)

3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2017
2	EpitopesIBA 01/2019 - 01/2017
2	Bortezomib (Velcade)FDA Link 01/2017 - 11/2016
1	VaccinesIBA 01/2022
1	Purinergic P2Y Receptor AntagonistsIBA 01/2022
1	Angiotensin IIIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	Factor XIIa (Coagulation Factor XIIa)IBA 01/2022
1	AnticoagulantsIBA 10/2020
1	RivaroxabanIBA 10/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	nafamostatIBA 01/2020
1	Angiotensin-Converting Enzyme 2IBA 01/2020
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	Thrombin FDA Link 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 08/2019
1	LipidsIBA 08/2019
1	Biomarkers (Surrogate Marker)IBA 08/2019
1	Cytotoxins (Cytolysins)IBA 01/2019
1	Reducing AgentsIBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	Cathepsin BIBA 01/2019
1	IntegrinsIBA 01/2019
1	monomethyl auristatin EIBA 01/2019
1	Platelet Membrane Glycoprotein IIbIBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018
1	von Willebrand FactorIBA 01/2017
1	Factor VIII (Coagulation Factor VIII)IBA 01/2017
1	Contrast MediaIBA 01/2017
1	thiamine triphosphorate (TTP)IBA 11/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2016
1	Rituximab (Mabthera)FDA Link 11/2016
1	Proteins (Proteins, Gene)FDA Link 02/2014

Therapy/Procedure

9	Therapeutics 01/2022 - 11/2016
2	Precision Medicine 01/2022 - 01/2017
2	Transcatheter Aortic Valve Replacement 11/2020 - 02/2019
1	Percutaneous Coronary Intervention 01/2022
1	Thrombolytic Therapy 07/2021
1	Drug Therapy (Chemotherapy) 01/2019
1	Lab-On-A-Chip Devices 01/2017
1	Salvage Therapy 11/2016